Komori
Financial results presentation7745A&D HOLON Holdings Company,LimitedElectrical Equipment and Precision Instruments

Earnings Briefing Report (Transcript) for the Fiscal Year Ending March 2026

For the fiscal year ended March 2026, revenue and operating profit increased, while net income declined due to costs incurred in response to violations of the Measurement Act and an extraordinary loss arising from improper expenditures by a Korean subsidiary. From the fiscal year ending March 2027 onward, the company factored in an adjustment in semiconductor demand, slower growth in EV-related investment, US tariffs and other factors, and revised its full-year forecast and medium-term management plan downward.

Worth reading
93Important
Scored from 5 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
243
¥ million
Wording
Avoiding a definitive answer
How definitive the wording is.

Contents of this document

Financial results presentationFiscal year ending March 202612 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥69,326 million+3.3%
Operating profit¥9,209 million+4.5%
Ordinary income¥9,470 million+5.8%
Net income¥5,923 million-8.4%
Gross Profit Margin45.4%
Operating profit margin13.3%
Selling, general and administrative expenses¥22,241 million
Results for the three months of the current quarter
Net Sales
Fourth quarter of the fiscal year ended March 2026¥20,694 million
Operating profit
Fourth quarter of the fiscal year ended March 2026¥3,561 million
Year on year against the same period last yearRevenue +9.1%, operating profit +29.1%
Full-year earnings forecast
Fiscal year ending March 2027
Net Sales
¥68,000 million
Operating profit
¥7,000 million
Dividends
¥60 per share
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Revenue for the fiscal year ended March 202699.0%
Operating profit, fiscal year ended March 202696.9%
Ordinary income for the fiscal year ended March 2026100.7%
Net income for the fiscal year ended March 202691.1%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Slightly below the full-year forecast
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Change in operating profit
Impact on sales¥351 million
Impact of changes in costs¥406 million
Impact of changes in miscellaneous expenses¥-647 million
Foreign exchange impact on sales and miscellaneous expenses¥286 million
Extraordinary loss
Provision for losses related to the Measurement Act¥552 million
Loss due to embezzlement¥243 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Assumed Exchange RatesUS$1 = ¥150.00, RUB1 = ¥1.90
Semiconductor demand in the Chinese marketRecovery assumed from the fiscal year ending March 2028
U.S. tariffsAssumes the impact will continue for the time being
New initiatives
  • Release of the next-generation CD-SEM HSS-1000
  • Start of operations at ホロン’s new plant
  • Construction of a new R&D center building
  • Restructuring of domestic production sites
  • Acquisition of an inspection equipment business in North America
  • Joint research program with Jichi Medical University
  • Establishment of a Global Marketing Division
  • Introduction of a generative AI platform
Key KPIsA metric the company considers important as a management benchmark.
  • Order backlog, semiconductor-related business¥3,359 million
    Year on year against the same period last year-6435 million yen
  • Order backlog, measurement and weighing instruments business¥5,228 million
    Year on year against the same period last year-1042 million yen
  • Order backlog, medical and healthcare equipment business¥543 million
    Year on year against the same period last year+216 million yen
  • ROE12.9 %
    Year on year against the same period last year-3.2 percentage points
  • Equity ratio65.7 %
  • Number of IR meetings98 times
  • PBR2.12 times
  • PER15.03 times
Segment results
Semiconductor-Related Business
Net Sales
¥11,114 million
Year-on-year change in revenue-9.6%
Operating profit
¥3,628 million
Year-on-year operating profit growth-12.0%
Measurement and weighing instruments business
Net Sales
¥31,545 million
Year-on-year change in revenue+2.9%
Operating profit
¥3,387 million
Year-on-year operating profit growth+25.2%
Medical and healthcare equipment business
Net Sales
¥26,667 million
Year-on-year change in revenue+10.5%
Operating profit
¥4,009 million
Year-on-year operating profit growth-2.4%
Medium-term management plan targets
ThemeRedefining business value and rebuilding the foundation
Revised plan for the fiscal year ending March 2027
Net Sales680 Hundreds of millions of yen
Operating profit70 Hundreds of millions of yen
Revised plan for the fiscal year ending March 2028
Net Sales755 Hundreds of millions of yen
Operating profit99 Hundreds of millions of yen
Comparison with actual results for the fiscal year ended March 2026Revenue of ¥69.3 billion and operating profit of ¥9.2 billion
Financial targets
ROEPolicy of exceeding the 9.5–10.5% cost of shareholders’ equity
Actual ROE12.9%
Actual equity ratio65.7%
Orders received and order backlog
Order backlog
Semiconductor-Related Business3,359
Measurement and weighing instruments business5,228
Medical and healthcare equipment business543
Capital expenditures
¥3,797 million
Annual Dividend
Fiscal year ending March 2026
Annual¥55 per share
Interim¥25 per share
End of period¥30 per share
Forecast for the fiscal year ending March 2027
Annual¥60 per share
Interim¥30 per share
End of period¥30 per share
Payout ratio
Forecast for the fiscal year ending March 202736.5 %
Policy during the medium-term management plan periodMaintain at 30%
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredFiscal year ending March 2026
Net Sales¥69,326 million (YoY +3.3%)
Operating profit¥9,209 million (YoY +4.5%)
Ordinary income¥9,470 million (YoY +5.8%)
Net income¥5,923 million (YoY -8.4%)
Gross Profit Margin45.4%
Operating profit margin13.3%
Selling, general and administrative expenses¥22,241 million
Results for the three months of the current quarterNet Sales ¥20,694 million / Operating profit ¥3,561 million / Year on year against the same period last year Revenue +9.1%, operating profit +29.1%
Full-year earnings forecastSubject Fiscal year ending March 2027 / Net Sales ¥68,000 million / Operating profit ¥7,000 million / Dividends ¥60 per share
Progress against full-year forecastRevenue for the fiscal year ended March 2026 99.0% / Operating profit, fiscal year ended March 2026 96.9% / Ordinary income for the fiscal year ended March 2026 100.7% / Net income for the fiscal year ended March 2026 91.1%
Self-assessment against the planSlightly below the full-year forecast
Segment resultsSemiconductor-Related Business Net Sales ¥11,114 million / Year-on-year change in revenue -9.6% / Operating profit ¥3,628 million / Year-on-year operating profit growth -12.0% / Measurement and weighing instruments business Net Sales ¥31,545 million / Year-on-year change in revenue +2.9% / Operating profit ¥3,387 million / Year-on-year operating profit growth +25.2% / Medical and healthcare equipment business Net Sales ¥26,667 million / Year-on-year change in revenue +10.5% / Operating profit ¥4,009 million / Year-on-year operating profit growth -2.4%
Breakdown of Factors Affecting the ChangeChange in operating profit Impact on sales ¥351 million / Impact of changes in costs ¥406 million / Impact of changes in miscellaneous expenses ¥-647 million / Foreign exchange impact on sales and miscellaneous expenses ¥286 million / Extraordinary loss Provision for losses related to the Measurement Act ¥552 million / Loss due to embezzlement ¥243 million
Key KPIsOrder backlog, semiconductor-related business ¥3,359 million, Order backlog, measurement and weighing instruments business ¥5,228 million, Order backlog, medical and healthcare equipment business ¥543 million, ROE 12.9 %, Equity ratio 65.7 %, Number of IR meetings 98 times, PBR 2.12 times, PER 15.03 times
Assumptions Underlying the Business OutlookAssumed Exchange Rates US$1 = ¥150.00, RUB1 = ¥1.90 / Semiconductor demand in the Chinese market Recovery assumed from the fiscal year ending March 2028 / U.S. tariffs Assumes the impact will continue for the time being
Medium-term management plan targetsTheme Redefining business value and rebuilding the foundation / Revised plan for the fiscal year ending March 2027 Net Sales 680 Hundreds of millions of yen / Operating profit 70 Hundreds of millions of yen / Revised plan for the fiscal year ending March 2028 Net Sales 755 Hundreds of millions of yen / Operating profit 99 Hundreds of millions of yen / Comparison with actual results for the fiscal year ended March 2026 Revenue of ¥69.3 billion and operating profit of ¥9.2 billion
Financial targetsROE Policy of exceeding the 9.5–10.5% cost of shareholders’ equity / Actual ROE 12.9% / Actual equity ratio 65.7%
Annual DividendFiscal year ending March 2026 Annual ¥55 per share / Interim ¥25 per share / End of period ¥30 per share / Forecast for the fiscal year ending March 2027 Annual ¥60 per share / Interim ¥30 per share / End of period ¥30 per share
Payout ratioForecast for the fiscal year ending March 2027 36.5 % / Policy during the medium-term management plan period Maintain at 30%
Capital expenditures¥3,797 million
Orders received and order backlogOrder backlog Semiconductor-Related Business 3,359 / Measurement and weighing instruments business 5,228 / Medical and healthcare equipment business 543
New initiativesRelease of the next-generation CD-SEM HSS-1000, Start of operations at ホロン’s new plant, Construction of a new R&D center building, Restructuring of domestic production sites, Acquisition of an inspection equipment business in North America, Joint research program with Jichi Medical University, Establishment of a Global Marketing Division, Introduction of a generative AI platform
Items this document does not state (7)
Unit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookAcquisition of treasury sharesMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

For the fiscal year ended March 2026, higher earnings in the measurement and weighing instruments business and improved profitability in DSP equipment pushed up operating profit, while higher costs, including US tariffs, overseas personnel expenses and sales promotion expenses, weighed on profit. The decline in net income was due to the recognition as an extraordinary loss of ¥552 million in corrective measures related to violations of the Measurement Act and ¥243 million in embezzlement losses at a Korean subsidiary. The plan revisions from the fiscal year ending March 2027 onward reflect adjustments in semiconductor investment in the Chinese market, slower growth in the EV-related market, US tariffs and the impact of foreign exchange movements.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Earnings Briefing Report (Transcript) for the Fiscal Year Ending March 2026 | A&D HOLON Holdings Company,Limited (7745) timely disclosure | Komori